BioTelemetry, Inc. Net Change in Cash
BioTelemetry, Inc. reported Net Change in Cash of $21.61 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2020-10-29
- BioTelemetry, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $38.23M.
- BioTelemetry, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$35.40M.
- BioTelemetry, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$12.28M, a 127.36% decline from fiscal 2018.
- BioTelemetry, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was $44.87M, a 245.93% increase from fiscal 2017.
- BioTelemetry, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2017 was $12.97M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2020-09-30 | $21.61M 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | $15.39M 10-Q · filed 2020-07-31 | |||
| 2020-03-31 | $38.23M 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | -$12.28M 10-K · filed 2020-02-28 | |||
| 2019-09-30 | -$19.32M 10-Q · filed 2020-10-29 | |||
| 2019-06-30 | -$29.18M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | -$35.40M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $44.87M 10-K · filed 2020-02-28 | |||
| 2017-12-31 | $12.97M 10-K · filed 2020-02-28 |